Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Endeavor Biomedicines, Inc., explained in plain language.
This study is testing whether a new drug called ENV-101 can help slow down lung scarring and improve breathing in adults with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 213 participants will receive either one of three doses of ENV-101 or a placebo for six…
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC